UAB "Molekulinės biotechnologijos centras" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataIndicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
276,721 |
62,607 |
12,071 |
10,112 |
2,288 |
73.64 |
3.65 |
12,861 |
28,944 |
0 |
41,805 |
2023 |
---|
274,029 |
69,374 |
22,690 |
19,397 |
4,911 |
11.26 |
7.08 |
22,147 |
92,208 |
0 |
114,217 |
2024 |
---|
323,448 |
81,473 |
35,156 |
29,714 |
7,485 |
12.54 |
9.19 |
51,860 |
68,352 |
120,212 |
0 |
Register and
explore Okredo data2024 |
---|
323,448 |
81,473 |
35,156 |
29,714 |
7,485 |
12.54 |
9.19 |
51,860 |
68,352 |
120,212 |
0 |
Register and
explore Okredo data2024
Turnover (€)
323,448 €18 % *
Sales per employee (€)
81,473 €17 % *
Profit before tax (€)
35,156 €55 % *
Net Profit (€)
29,714 €53 % *
Profit per employee (€)
7,485 €52 % *
Total profitability (%)
12.54 %11.37 % *
Net profitability (%)
9.19 %29.80 % *
Equity (€)
51,860 €134 % *
Amounts Payable And Liabilities (€)
68,352 €-26 % *
Non-current Assets (€)
120,212 €- *
CurrentAssets (€)
0 €-100 % *